Spergel Lecture Series: An Insider's View of What I Saw at the Apocalypse
AC-2D01 and Zoom
Why did the "most pandemic prepared country in the world" lose one million lives? The short answer: you can have the best science but informed, effective and intelligent leadership is essential.
Steven J. Projan, Ph.D., FAAM
Dr. Steve Projan currently works as a consultant and scientific advisor in the biopharmaceutical industry as well as with public-private partnerships, mainly in infectious disease research.
Dr. Projan was, until April 1, 2018, the Head of the Infectious Diseases & Vaccines Innovative Medicines unit (iMED) at MedImmune, leading a cross-functional team dedicated to the therapeutic area strategy, prioritization, and advancement of the company’s infectious disease and vaccine portfolio.
Dr. Projan joined MedImmune in 2010. Prior to joining MedImmune, Dr. Projan served as vice president and global head of Infectious Diseases at the Novartis Institutes for Biomedical Research in Cambridge MA. He previously spent 15 years at Wyeth in roles of increasing responsibility with his last post as vice president and head of Biological Technologies. During his time at Wyeth, Dr. Projan started the Biologics Discovery Group (covering all therapeutic areas) and initiated multiple collaborations and partnerships, most notably with Cambridge Antibody Technology (now a part of MedImmune/AZ). Prior to Dr. Projan’s work in the industry, he spent 14 years at the Public Health Research Institute and presently has over 120 publications to his credit.